Psychometric Properties of the Drug Stigma Scale Among Community Pharmacists Concerning Individuals Who Use Over-The-Counter Drugs. [PDF]
Katayama M +9 more
europepmc +1 more source
Sterile syringe availability in Georgia pharmacies remained rare, despite policy change permitting sales. [PDF]
Yarbrough CR +7 more
europepmc +1 more source
The use and misuse of non-steroidal anti-inflammatory drugs (Ibuprofen) and paracetamol among mothers who presented with their children in health facilities in Enugu, South‒East Nigeria. [PDF]
Onyia JT +7 more
europepmc +1 more source
Availability and cost of naloxone over time: A longitudinal secret shopper study in North Carolina community pharmacies. [PDF]
Johnson JM +3 more
europepmc +1 more source
Self-Prescribed Analgesic Use for Acute Dental Pain Among Saudi Adults: A Cross-Sectional Study. [PDF]
Alsnani M.
europepmc +1 more source
Over-the-Counter Naloxone and Nonprescription Syringe Availability in Community Pharmacies.
Loera LJ +5 more
europepmc +1 more source
Estimates of Illicit Opioid Use in the US.
Powell D, Jacobson M.
europepmc +1 more source
Prevalence of Over-the-Counter and Prescription Medication Use in the US.
Green JL +3 more
europepmc +1 more source
Related searches:
Nonprescription Drugs: An Overview
International Journal of Health Services, 1974This article discusses a widely used class of medicinal agents—nonprescription drugs. The pertinent legislation affecting nonprescription drugs is reviewed historically, followed by a discussion of recent federal regulatory actions, especially those of the review panels convened by the United States Food and Drug Administration. The problems associated
exaly +3 more sources
Nonprescription Drugs in Germany
Drug Information Journal, 1994Nonprescription medicinal products, which include over-the-counter and some homeopathic and herbal medicines, comprise a large part of the pharmaceutical market in Germany, accounting for 35% of all sales in 1992. This paper reviews definitions, markets, the legal framework, and future prospects.
exaly +2 more sources

